Increased risk of thrombo-embolic events in patients with anti-phopholipid syndrome (APS) treated with Xarelto

Increased risk of thrombo-embolic events in patients with anti-phopholipid syndrome (APS) treated with Xarelto

2019 Aug

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 15/08/2019
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance